46 unknown. 46 Phase 3, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 46 | Unknown 46 |
| Phase 2 | 10 | Unknown 10 |
Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma | Phase 3 | Unknown | Respirent Pharmaceuticals Co Ltd. | 451 | 2023-01-30 | 2023-03-01 |
| Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler - Bronchial Asthma | Phase 3 | Unknown | Glenmark Pharmaceuticals Ltd. India | 790 | 2022-04-15 | 2022-05-27 |
| Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer osimertinib oral and bevazizumab intravenously - Carcinoma, Non-Small-Cell Lung | Phase 3 | Unknown | Qingdao Central Hospital | 60 | 2021-01-01 | 2023-03-29 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients. 4-Aminopyridine, Placebo oral capsule - Spinal Cord Injuries, Chronic | Phase 3 | Unknown | Coordinación de Investigación en Salud, Mexico | 150 | 2019-07-17 | 2021-02-21 |
| Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma Doxophylline, Budesonide - Asthma Chronic, Asthma in Children | Phase 3 | Unknown | Universidad Autonoma de Nuevo Leon | 60 | 2019-05-01 | 2019-03-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis DW1601, DW16011, DW16012 - Acute Bronchitis | Phase 3 | Unknown | Daewon Pharmaceutical Co., Ltd. | 204 | 2018-12-20 | 2020-02-07 |
| Clinical Trials to Assess the Efficacy and Safety of HLIM Test, Active Comparator Control 1, Active Comparator Control 2 - Acute Upper Respiratory Tract Infection, Acute Bronchitis | Phase 3 | Unknown | SamA Pharmaceutical Co., Ltd | 487 | 2018-11-29 | 2019-02-08 |
| Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa Tobramycin Inhalant Product, usual care, Natural saline inhalation - Bronchiectasis Adult, Pseudomonas Infections | Phase 3 | Unknown | Guangzhou Institute of Respiratory Disease | 350 | 2018-10-26 | 2019-08-02 |
| A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 Test Product, Reference Product, Placebo - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 1204 | 2018-10-01 | 2018-06-20 |
| BDD With UDCA Therapy After Laparoscopic Cholecystectomy BDD with UDCA, Placebo - Cholecystitis, Acute, Cholecystitis, Chronic | Phase 3 | Unknown | Ewha Womans University Mokdong Hospital | 172 | 2018-04-24 | 2018-07-18 |
| Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base Placebo, 90 mcg Reference Product, 180 mcg Reference Product - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 100 | 2018-03-16 | 2018-06-14 |
| Effects of Traditional Chinese Medicine on Bronchiectasis Patients Bufei Huatan granule, Yifei Qinghua granule, Placebo Bufei Huatan granule - Bronchiectasis | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 216 | 2018-03-01 | 2018-02-23 |
| The Effect of Benralizumab on Exercise-induced Bronchoconstriction Benralizumab - Asthma, Exercise-Induced | Phase 3 | Unknown | Louis-Philippe Boulet | 40 | 2017-12-01 | 2017-10-31 |
| Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years Fluticasone/ Formoterol, fluticasone/ salmeterol - Asthma | Phase 3 | Unknown | Mundipharma (China) Pharmaceutical Co. Ltd | 330 | 2017-06-02 | 2019-04-29 |
| Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 300 | 2017-04-01 | 2018-03-12 |
| A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection Recombinant human Apo-2 ligand for Injection, Placebo - Non-small-cell Lung Cancer (NSCLC) Stage IV | Phase 3 | Unknown | Shanghai Gebaide Biotechnology Co., Ltd. | 417 | 2016-10-01 | 2017-03-20 |
| Effect of Reslizumab in Chronic Rhinosinusitis Reslizumab, Placebo - Sinusitis | Phase 3 | Unknown | Joshua S. Jacobs | 30 | 2016-06-01 | 2018-02-01 |
Showing 20 of 46. Sign in to see all of them.
Asthma (27) · Bronchiolitis Obliterans Syndrome (7) · Bronchitis (5) · Bronchial Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (3) · Bronchiectasis (2) · Carcinoma, Bronchogenic (2) · Cough (2) · Inflammation (2) · Lung Diseases (2) · Lung Neoplasms (2) · Lymphoma, Follicular (2) · Neoplasms (2) · Status Asthmaticus (2) · Thoracic Neoplasms (2)
Respiratory Tract Diseases (45) · Lung Diseases (41) · Lung Diseases, Obstructive (39) · Immune System Diseases (35) · Hypersensitivity, Immediate (28) · Respiratory Hypersensitivity (28) · Hypersensitivity (27) · Bronchitis (8) · Infections (8) · Bronchiolitis (7) · Bronchiolitis Obliterans (7) · Graft vs Host Disease (7) · Organizing Pneumonia (7) · Pathological Conditions, Signs and Symptoms (7)
Budesonide (5) · Fluticasone-Salmeterol Drug Combination (4) · montelukast (4) · Azithromycin (2) · Fluticasone (2) · Salmeterol Xinafoate (2) · 4-Aminopyridine (1) · 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester (1) · Albuterol (1) · Bevacizumab (1) · Breathing Exercises (1) · Bronchial Thermoplasty (1) · Carboplatin (1) · Cyclosporine (1) · Docetaxel (1)
Amneal Ireland Limited (2) · Assistance Publique - Hôpitaux de Paris (2) · EMS (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ajou University School of Medicine (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Chinese Academy of Medical Sciences (1) · Cimera (1) · Coordinación de Investigación en Salud, Mexico (1) · Daewon Pharmaceutical Co., Ltd. (1) · Engelhard Arzneimittel GmbH & Co.KG (1) · Ewha Womans University Mokdong Hospital (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Glenmark Pharmaceuticals Ltd. India (1)
China (8) · United States (4) · Brazil (3) · South Korea (3) · United Kingdom (3) · France (2) · Germany (2) · India (2) · Mexico (2) · Spain (2) · Finland (1) · Greece (1) · Israel (1) · Italy (1) · Japan (1)
Irshad Haque (2) · Alok Nath, MD (1) · Ameet Daftary (1) · Andreas M Zeiher, MD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Aubier Michel (1) · Birgit Assmus, MD (1) · Christopher Corrigan, MD, PhD (1) · Chunhua Zhao, MD,PHD (1) · Elisabeth H Bel, MD, PhD (1) · Emmanuelle Dexeus Gabriel Fernandez, pediatrician (1) · Eran Rom, Dr. (1) · Erkki Savilahti, Professor (1)
PMID 36472162, PMID 17356056, PMID 18595980, PMID 19535666, PMID 19726699, PMID 19797480, PMID 19817753, PMID 20420722, PMID 20525652, PMID 20526242, PMID 20538327, PMID 20620566, PMID 20870246, PMID 21315433, PMID 21771118, PMID 21986034, PMID 22093109, PMID 22330698, PMID 22532985, PMID 23595876, PMID 23792089, PMID 24067388, PMID 24447429, PMID 24506910, PMID 24650447, PMID 24698320, PMID 24838406, PMID 24989842, PMID 25277142, PMID 25631639, PMID 25640020, PMID 25643669, PMID 25724847, PMID 25732539, PMID 25749414, PMID 25835160, PMID 25845986, PMID 25899478, PMID 26019776, PMID 26063507, PMID 27824606, PMID 28298402, PMID 28318759, PMID 28787506, PMID 29031617, PMID 30326954, PMID 30472801, PMID 30722097, PMID 34857814, PMID 35863486
2009 (1)